What is the differential diagnosis and what additional laboratory tests are indicated for an adult with recent pneumonia, cellulitis, sepsis, and known anemia of chronic disease who now has severe normocytic‑to‑macrocytic anemia, elevated red cell distribution width, mild thrombocytopenia, schistocytes on peripheral smear, a low albumin/globulin ratio, modestly elevated alkaline phosphatase, and iron studies consistent with functional iron deficiency?

Differential Diagnosis and Workup for Severe Anemia with Schistocytes in a Septic Patient

This patient requires immediate evaluation for microangiopathic hemolytic anemia (MAHA), specifically thrombotic microangiopathy (TMA) or disseminated intravascular coagulation (DIC), given the presence of schistocytes, severe anemia, and thrombocytopenia in the setting of sepsis.

Key Clinical Findings Requiring Urgent Attention

The laboratory profile reveals several critical abnormalities:

• Severe normocytic anemia (Hgb 8.8 g/dL, Hct 27.2%) with markedly elevated RDW (20.7%), indicating significant red cell size heterogeneity 1
• Schistocytes on peripheral smear – this is the most concerning finding suggesting red cell fragmentation from mechanical destruction 2
• Thrombocytopenia (platelets 125 × 10⁹/L) 2
• Abnormal white cell differential with elevated basophils (11% auto, 3% manual) and monocytosis (15.3%)
• Low albumin/globulin ratio (0.9) suggesting chronic inflammation or protein loss 2
• Functional iron deficiency pattern: iron saturation 27% with TIBC 222, which in the context of inflammation suggests anemia of chronic disease with possible coexisting iron deficiency 2

Primary Differential Diagnosis

1. Microangiopathic Hemolytic Anemia (MAHA) – Most Urgent

The presence of schistocytes mandates evaluation for:

• Sepsis-associated DIC (most likely given recent sepsis)
• Thrombotic thrombocytopenic purpura (TTP)
• Hemolytic uremic syndrome (HUS)
• Drug-induced TMA

2. Anemia of Chronic Disease with Hemolysis

The iron saturation of 27% with recent infections suggests functional iron deficiency in the setting of inflammation 2. However, this does not explain the schistocytes 3.

3. Combined Nutritional Deficiency

The elevated RDW (20.7%) indicates a mixed population of red cells, which can occur when microcytosis and macrocytosis coexist 2, 1. This suggests possible concurrent deficiencies.

4. Bone Marrow Suppression/Infiltration

The pancytopenia pattern (anemia + thrombocytopenia + abnormal WBC differential) raises concern for marrow pathology 2.

Essential Additional Laboratory Tests

Immediate Priority Tests (Within Hours)

To evaluate for MAHA/DIC:

• Lactate dehydrogenase (LDH) – elevated in hemolysis 2
• Haptoglobin – decreased in hemolysis 2
• Direct and indirect bilirubin – indirect elevated in hemolysis 2
• Coagulation studies: PT/INR, aPTT, fibrinogen, D-dimer – to assess for DIC 2
• ADAMTS13 activity and inhibitor – if TTP suspected (though less likely with sepsis context)

To assess erythropoiesis:

• Reticulocyte count with corrected reticulocyte index – distinguishes production vs. destruction/loss 2
• Low reticulocyte count suggests inadequate marrow response 2
• High reticulocyte count suggests hemolysis or blood loss 2

Secondary Priority Tests (Within 24-48 Hours)

To evaluate nutritional deficiencies:

• Vitamin B12 level – macrocytosis contributor 2
• Folate level – macrocytosis contributor 2
• Ferritin level – essential for iron status interpretation. In the presence of inflammation (which this patient has), ferritin <100 μg/L suggests iron deficiency, while ferritin >100 μg/L with transferrin saturation <20% indicates anemia of chronic disease 2

To assess inflammation:

• C-reactive protein (CRP) – helps interpret ferritin levels and confirms inflammatory state 2
• Erythrocyte sedimentation rate (ESR) – additional inflammation marker 2

Advanced red cell parameters (if available):

• Percentage of hypochromic red cells – functional iron deficiency marker 2
• Reticulocyte hemoglobin content (CHr) – identifies iron-restricted erythropoiesis 2

Tertiary Evaluation (If Initial Workup Non-Diagnostic)

• Peripheral blood smear review by hematopathologist – comprehensive morphology assessment 2
• Bone marrow aspiration and biopsy – if pancytopenia persists or cause remains unclear 2
• Flow cytometry – if hematologic malignancy suspected
• Renal function tests (creatinine, BUN) – anemia of chronic kidney disease consideration 2, 4

Diagnostic Algorithm Based on Reticulocyte Count

If reticulocyte index is LOW (<2.0):

• Suggests hypoproliferative anemia 2
• Consider: anemia of chronic disease, nutritional deficiencies (iron, B12, folate), bone marrow failure, or drug-induced marrow suppression 2
• The schistocytes would then suggest concurrent hemolysis superimposed on production defect

If reticulocyte index is HIGH (>2.0):

• Suggests hemolytic anemia or acute blood loss 2
• With schistocytes present, this confirms MAHA 2
• Proceed immediately with hemolysis workup (LDH, haptoglobin, bilirubin) and DIC evaluation

Critical Clinical Pitfalls

Do not dismiss schistocytes as artifact – their presence in a septic patient with thrombocytopenia is pathognomonic for microangiopathy until proven otherwise 2.

Do not rely solely on ferritin in inflammatory states – ferritin is an acute phase reactant and can be falsely elevated despite true iron deficiency 2. In this patient with recent infections, ferritin between 30-100 μg/L would suggest combined iron deficiency and anemia of chronic disease 2.

Do not overlook the elevated RDW – RDW >15% has 90% sensitivity for iron deficiency but can also indicate mixed deficiencies or hemolysis 5, 6. The markedly elevated RDW (20.7%) in this case suggests either severe iron deficiency, mixed nutritional deficiencies, or active hemolysis with reticulocytosis 1.

Do not delay hematology consultation – the combination of schistocytes, thrombocytopenia, and severe anemia in a septic patient requires urgent specialist input to guide management and determine if plasmapheresis or other emergent interventions are needed 2.